Immunometabolic reprogramming of the HCC tumor microenvironment via nutritional metabolites: how bile acids, SCFAs, and sphingolipids reshape macrophage polarization, T-cell exhaustion, and the response to anti-PD-1 therapy

Hepatocellular carcinoma (HCC) represents one of the most lethal malignancies worldwide, with limited therapeutic efficacy despite advances in immune checkpoint inhibitor (ICI) therapy. The tumor microenvironment (TME) in HCC is characterized by profound metabolic alterations that critically influence immune cell function. This review examines the immunometabolic reprogramming of the HCC microenvironment mediated by three key classes of nutritional metabolites: bile acids, short-chain fatty acids (SCFAs), and sphingolipids. Studies have provided mechanistic insights into metabolite-driven immune cell reprogramming. Bile acids, particularly through the activation of FXR and TGR5 receptors, orchestrate macrophage polarization dynamics, with secondary bile acids such as deoxycholic acid (DCA) promoting M2-like tumor-associated macrophage (TAM) polarization conducive to tumor progression. SCFAs, including butyrate and propionate, enhance CD8+ T-cell functionality and improve anti-PD-1 therapeutic responses by modulating T-cell receptor signaling and memory formation. Sphingolipids, especially ceramides and sphingosine-1-phosphate, regulate T-cell exhaustion programs and natural killer T (NKT) cell activation, with distinct sphingolipid species exhibiting opposing effects on antitumor immunity. Nutritional metabolites function as critical signaling molecules that reshape the immunosuppressive HCC microenvironment. Understanding these immunometabolic crosstalk pathways offers novel therapeutic avenues for overcoming resistance to anti-PD-1 therapy and improving patient outcomes.

Authors

Institutions

Publication Details

Journal
Frontiers in Physiology
Published
2026-11-13
DOI
https://doi.org/10.3389/fphys.2026.1919932
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Immunometabolic reprogramming of the HCC tumor microenvironment via nutritional metabolites: how bile acids, SCFAs, and sphingolipids reshape macrophage polarization, T-cell exhaustion, and the response to anti-PD-1 therapy

Yigan Zhang, 丁德平, Zhongji Meng, Shuangsuo Dang
4 links
Frontiers in Physiology
Immune cells in cancer
article

Immunometabolic reprogramming of the HCC tumor microenvironment via nutritional metabolites: how bile acids, SCFAs, and sphingolipids reshape macrophage polarization, T-cell exhaustion, and the response to anti-PD-1 therapy

Yigan Zhang, 丁德平, Zhongji Meng, Shuangsuo Dang
article en

Abstract

Hepatocellular carcinoma (HCC) represents one of the most lethal malignancies worldwide, with limited therapeutic efficacy despite advances in immune checkpoint inhibitor (ICI) therapy. The tumor microenvironment (TME) in HCC is characterized by profound metabolic alterations that critically influence immune cell function. This review examines the immunometabolic reprogramming of the HCC microenvironment mediated by three key classes of nutritional metabolites: bile acids, short-chain fatty acids (SCFAs), and sphingolipids. Studies have provided mechanistic insights into metabolite-driven immune cell reprogramming. Bile acids, particularly through the activation of FXR and TGR5 receptors, orchestrate macrophage polarization dynamics, with secondary bile acids such as deoxycholic acid (DCA) promoting M2-like tumor-associated macrophage (TAM) polarization conducive to tumor progression. SCFAs, including butyrate and propionate, enhance CD8+ T-cell functionality and improve anti-PD-1 therapeutic responses by modulating T-cell receptor signaling and memory formation. Sphingolipids, especially ceramides and sphingosine-1-phosphate, regulate T-cell exhaustion programs and natural killer T (NKT) cell activation, with distinct sphingolipid species exhibiting opposing effects on antitumor immunity. Nutritional metabolites function as critical signaling molecules that reshape the immunosuppressive HCC microenvironment. Understanding these immunometabolic crosstalk pathways offers novel therapeutic avenues for overcoming resistance to anti-PD-1 therapy and improving patient outcomes.

Frontiers in PhysiologyVol. 17
Hubei University of Medicine (CN), Taihe Hospital (CN), Second Affiliated Hospital of Xi'an Jiaotong University (CN)
National Natural Science Foundation of China
Good health and well-being
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon